
    
      This was a prospective, double-blind, randomized, placebo-controlled, crossover desigh,
      multicenter study of the safety and effectiveness of subcutaneous apomorphine treatment.
      Patients received both apomorphine and placebo, in a randomized double-blind fashion
    
  